ArticleCancers2021

Infection Complications after Lymphodepletion and Dosing of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or B Cell Non-Hodgkin Lymphoma.

Felix Korell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.